Trends in Spending on Selective Beta 2 Agonists in General Practice in England.

Slides:



Advertisements
Similar presentations
% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England.
Advertisements

Phamacology Final Exam Review.
PROBLEMS OF ASTHMA MANAGEMENT IN PAKISTAN. BURDEN OF ASTHMA ASTHMA IS ONE OF THE MOST COMMON CHRONIC DISEASE WORLDWIDE PREVALENCE INCREASING IN MANY COUNTRIES.
DRUG THERAPY OF AIRFLOW OBSTRUCTION PROFESSOR B J LIPWORTH Preventers (anti-inflammatory)Preventers (anti-inflammatory) Relievers (bronchodilators)Relievers.
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014.
Clinical Knowledge Summaries CKS Chronic obstructive pulmonary disease (COPD) - management Management of stable COPD in primary care, focusing on drug.
Drugs that Affect the Respiratory System P. Andrews Chemeketa Community College Paramedic Program Sp08.
Obstructive Lung Diseases infectionsIrritantsallergens (esp. smoking) Genetic Predisposition bronchospasm AsthmaEmphysema destruction of alveolar walls.
Management of COPD & Asthma Melissa Brittle & Jessica Macaro.
Drugs For Treating Asthma
Long-term Controller Asthma Medications
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Trends in Usage of Non-Opioid Analgesics in General Practice in England © Copyright NHSBSA 2008.
Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician.
Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.
Respiratory System PHARMACOLOGY
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Karen Homan NHS Bedfordshire
Bronchodilators ( 支气管扩张药 ) Huifang Tang ( 汤慧芳 ) Department of Pharmacology Zhejiang university, school of Medicine
Asthma Medications ESAT 4001 Pharmacology in Athletic Training.
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
Classification and guideline treatment
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
DRUGS USED IN ASTHMA. Asthma is an inflammatory disease of the airways characterized by episodes of acute bronchoconstriction causing shortness of breath,
Trends in Prescribing of Selected Alpha-Blockers in General Practice in England © Copyright NHSBSA 2008.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Trends in Prescribing of Sodium Chloride Irrigation Solutions in General Practice in England © Copyright NHSBSA 2008.
Anticholinergics in COPD presented by: Soha Ragab Moselhy group 2.
PharmacologyPharmacology Drugs used to treat: Asthma Rhinitis & Cough Drugs used to treat: Asthma Rhinitis & Cough.
Acute and chronic management of childhood asthma
U.S. Asthma Therapies Markets Growing Penetration of Combination Drugs Spur Growth “The tremendous success of bronchodilator/-corticosteroid combination.
% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009.
CHRONIC ASTHMA GUIDELINES IN ADOLESCENTS & ADULTS 2007 Bushra A. Hadi Asthma Guidelines Implementation Project.
Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008.
Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.
Treatments for Asthma Ghazaleh Ebrahimnejadalamaki, Gea Panić, Natali Surkic, Romina Isip [1] PHM142 Fall 2015 Coordinator: Dr. Jeffrey Henderson Instructor:
Disorders Of Respiratory System General Pharmacology M212
Responsible Respiratory Prescribing
ASTHMA. Definition Chronic inflammation is associated with airway hyper-responsiveness that leads to recurrent episodes of wheezing, breathlessness, chest.
1 © 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Clinical pharmacology of drugs acting on the respiratory organs function.
Drugs Used to Treat Asthma Dr. Najlaa Saadi Ismael Department of Pharmacology Mosul college of Medicine University of Mosul.
Respiratory medication use in Australia 2003–2013: Treatment of asthma and COPD AIHW: Correll PK, Poulos LM, Ampon R, Reddel HK and Marks GB. Published.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
New Therapies for Asthma & COPD
Lynn Helliwell.
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Department of Pharmacology
Management of Chronic Airflow Obstruction
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort  Rupert C M Jones,
WSCCG Prescribing Data
Challenges in recruiting primary care doctors for a randomized controlled trial to study change in prescription practices due to our educational intervention.
Respiratory disorders
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts
Drugs affecting the respiratory system
UNIT 8: DRUGS USED IN THE TREATMENT OF RESPIRATORY DISORDERS
Antonio Anzueto, MD, Marc Miravitlles, MD  CHEST 
Emergency Drug Therapy
Overcoming barriers to nonadherence in asthma treatment
Anticholinergics Review
12 months before treatment 12 months after treatment
Respiratory disorders
Drugs Acting on the Respiratory System
Biopharmaceutics Pharmacy Technician.
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort  Rupert C M Jones,
Drugs used in asthma.
Chronic Obstructive Pulmonary Disease
Presentation transcript:

Trends in Spending on Selective Beta 2 Agonists in General Practice in England

Trends in Usage of Selective Beta 2 Agonists in General Practice in England

Trends in Spending on Short-acting Selective Beta 2 Agonists in General Practice in England

Trends in Usage of Short-acting Selective Beta 2 Agonists in General Practice in England

Trends in Spending on Long-acting Selective Beta 2 Agonists in General Practice in England

Trends in Usage of Long-acting Selective Beta 2 Agonists in General Practice in England

Trends in Spending on Selective Beta 2 Agonists (by Device) in General Practice in England

Trends in Usage of Selective Beta 2 Agonists (by Device) in General Practice in England

Trends in Spending on Antimuscarinic Bronchodilators Including Combinations in General Practice in England

Trends in Usage of Antimuscarinic Bronchodilators Including Combinations in General Practice in England

Trends in Spending on Theophylline and Aminophylline in General Practice in England

Trends in Usage of Theophylline and Aminophylline in General Practice in England

Trends in Spending on Inhaled Corticosteroids (excluding Combinations) in General Practice in England

Trends in Usage of Inhaled Corticosteroids (excluding Combinations) in General Practice in England

Trends in Spending on Inhaled Corticosteroids (by Device) in General Practice in England

Trends in Usage of Inhaled Corticosteroids (by Device) in General Practice in England

Trends in Spending on Seretide® and Symbicort® in General Practice in England

Trends in Usage of Seretide® and Symbicort® in General Practice in England

Trends in Prescribing of Seretide® Inhaler by Strength in General Practice in England

Trends in Spending on Seretide® Inhaler by Strength in General Practice in England

Trends in Prescribing of Leukotriene Receptor Antagonists in General Practice in England

Trends in Spending on Leukotriene Receptor Antagonists in General Practice in England

Trends in Prescribing of Non-Sedating Antihistamines in General Practice in England

Trends in Spending on Non-Sedating Antihistamines in General Practice in England

Trends in Prescribing of Sedating Antihistamines in General Practice in England

Trends in Spending on Sedating Antihistamines in General Practice in England

Trends in Prescribing of Adrenaline (BNF Allergic Emergencies) in General Practice in England

Trends in Spending on Adrenaline (BNF Allergic Emergencies) in General Practice in England

Trends in Prescribing of Mucolytics (excluding Dornase Alfa) in General Practice in England

Trends in Spending on Mucolytics (excluding Dornase Alfa) in General Practice in England

Trends in Prescribing of and Spending on Nicotine Replacement Therapy in General Practice in England

Trends in Prescribing of Different Formulations of Nicotine Replacement Therapy in General Practice in England

Trends in Spending on Different Formulations of Nicotine Replacement Therapy in General Practice in England

Trends in Prescribing of and Spending on Bupropion in General Practice in England

Trends in Prescribing of and Spending on Varenicline in General Practice in England

Trends in Prescribing of NICE Drugs for Influenza in General Practice in England

Trends in Spending on NICE Drugs for Influenza in General Practice in England

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.